Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L S Kahn

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Expert Opinion on Pharmacotherapy|October 5, 2001
Oral contraceptives and moodL S Kahn, U Halbreich
Psychosomatic Medicine|May 31, 2001
Are women with premenstrual dysphoric disorder prone to osteoporosis?U Halbreich, L S Kahn
Psychoneuroendocrinology|March 26, 2003
Hormonal aspects of schizophrenias: an overviewU Halbreich, L S Kahn
CNS Drugs|October 17, 2001
Role of estrogen in the aetiology and treatment of mood disordersU Halbreich, L S Kahn
Expert Opinion on Pharmacotherapy|March 16, 2001
Selective oestrogen receptor modulators--current and future brain and behaviour applicationsU Halbreich, L S Kahn
Archives of Ophthalmology (Chicago, Ill. : 1960)|March 1, 1983
Serum immunoglobulins and uveitisL S Kahn, T F Schlaegel, J C Weber, et al.
Psychoneuroendocrinology|December 31, 2002
Elevated prolactin levels in patients with schizophrenia: mechanisms and related adverse effectsU Halbreich, B J Kinon, J A Gilmore, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Expert Opinion on Pharmacotherapy|October 5, 2001
Oral contraceptives and moodL S Kahn, U Halbreich
Psychosomatic Medicine|May 31, 2001
Are women with premenstrual dysphoric disorder prone to osteoporosis?U Halbreich, L S Kahn
Psychoneuroendocrinology|March 26, 2003
Hormonal aspects of schizophrenias: an overviewU Halbreich, L S Kahn
CNS Drugs|October 17, 2001
Role of estrogen in the aetiology and treatment of mood disordersU Halbreich, L S Kahn
Expert Opinion on Pharmacotherapy|March 16, 2001
Selective oestrogen receptor modulators--current and future brain and behaviour applicationsU Halbreich, L S Kahn
Archives of Ophthalmology (Chicago, Ill. : 1960)|March 1, 1983
Serum immunoglobulins and uveitisL S Kahn, T F Schlaegel, J C Weber, et al.
Psychoneuroendocrinology|December 31, 2002
Elevated prolactin levels in patients with schizophrenia: mechanisms and related adverse effectsU Halbreich, B J Kinon, J A Gilmore, et al.
Pageof 1